. Author manuscript; available in PMC: 2017 Sep 1.

Published in final edited form as: Am J Cardiol. 2016 Jun 14;118(5):684–690. doi: 10.1016/j.amjcard.2016.06.016

Table 2.

Multivariable-adjusted hazards ratios (95% confidence interval) for clinical outcomes by left ventricular mass and geometry

Parameter	Coronary Heart Disease	Cardiovascular Disease	Heart Failure
Echo-LVH (compared to no LVH)	1.47 (1.17–1.85)^*	1.50 (1.24–1.81)^*	2.57 (2.14–3.08)^*
Echo-LVMI (per 1-SD increase)	1.24 (1.14–1.37)^*	1.26 (1.15–1.33)^*	1.52 (1.41–1.63)^*
ECG-LVM (per 1-SD increase)	1.14 (1.04–1.25)^*	1.15 (1.07–1.24)^*	1.38 (1.30–1.47)^*
GEOMETRY
Normal geometry	1.0 (ref)	1.0 (ref)	1.0 (ref)
Concentric remodeling	1.47 (1.03–2.09)^*	1.37 (1.02–1.85)^*	1.24 (0.86–1.78)
Eccentric LVH	1.44 (1.12–1.85)^*	1.54 (1.26–1.89)^*	2.67 (2.20–3.23)^*
Concentric LVH	1.95 (1.17–3.24)^*	1.47 (0.93–2.31)	2.24 (1.43–3.50)^*

denotes P < 0.05

LVH = left ventricular hypertrophy; LVMI = left ventricular mass index; LVM = left ventricular mass; ECG = electrocardiographic; echo = echocardiographic

All models adjusted for age, race, sex, systolic blood pressure, hypertension medication, total cholesterol, HDL, diabetes, and smoking status